| 今开：0.0 | 昨收：0.4349 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1142059.0 |
IVD资讯2023-10-19 10:41
来源：360Dx ,IVD从业者网编译
液体活检公司Biocept上周在特拉华地区的美国破产法院提交了第7章破产申请。
总部位于圣迭戈的这家公司于周五提交了破产申请，随后在周一向美国证券交易委员会提交的文件中表示，它是在考虑战略替代方案后提交了申请。
Antonino Morales于周五辞去了公司...查看全文
美股滚雪球2023-09-11 09:59
$Biocept(BIOC)$ 宣布与$Plus Therapeutics(PSTV)$ 就其CNSide癌症检测测试达成许可协议，这项非排他性协议扩大了两家公司于2022年签署的实验室服务协议。
bioept (BIOC)表示，它允许Plus (PSTV)在其临床试验和商业中使用CNSide测试，等待监管部门的批准。Plus Therapeutics (PSTV)的股票在反...查看全文
Biocept(BIOC)2023-11-20 21:55
$Biocept(BIOC)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000871 Act: 34 Size: 3 KB 网页链接查看全文
Biocept(BIOC)2023-10-20 18:15
$Biocept(BIOC)$ 8-K Current report, item 3.01 Accession Number: 0001654954-23-013182 Act: 34 Size: 149 KB 网页链接查看全文
Biocept(BIOC)2023-10-16 20:55
$Biocept(BIOC)$ 8-K Current report, items 1.03 and 5.02 Accession Number: 0001654954-23-012952 Act: 34 Size: 144 KB 网页链接查看全文
Biocept(BIOC)2023-08-23 04:15
$Biocept(BIOC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-23-217997 Act: 34 Size: 213 KB 网页链接查看全文
Biocept(BIOC)2023-08-15 04:35
$Biocept(BIOC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-042468 Act: 34 Size: 8 MB 网页链接查看全文
Biocept(BIOC)2023-06-21 07:15
$Biocept(BIOC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-23-038625 Size: 4 KB 网页链接查看全文
Biocept(BIOC)2023-06-22 04:15
$Biocept(BIOC)$ 8-K Current report, item 5.02 Accession Number: 0001193125-23-171148 Act: 34 Size: 142 KB 网页链接查看全文
$Biocept(BIOC)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000871 Act: 34 Size: 3 KB 网页链接
$Biocept(BIOC)$ 8-K Current report, item 3.01 Accession Number: 0001654954-23-013182 Act: 34 Size: 149 KB 网页链接
$Biocept(BIOC)$ 8-K Current report, items 1.03 and 5.02 Accession Number: 0001654954-23-012952 Act: 34 Size: 144 KB 网页链接
$Biocept(BIOC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-23-217997 Act: 34 Size: 213 KB 网页链接
$Biocept(BIOC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-042468 Act: 34 Size: 8 MB 网页链接
$Biocept(BIOC)$ 8-K Current report, item 5.02 Accession Number: 0001193125-23-171148 Act: 34 Size: 142 KB 网页链接
$Biocept(BIOC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-23-038625 Size: 4 KB 网页链接
$Biocept(BIOC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-23-001627 Act: 34 Size: 81 KB 网页链接
$Biocept(BIOC)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001193125-23-154367 Act: 33 Size: 232 KB 网页链接
$Biocept(BIOC)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001517 Act: 33 Size: 1 KB 网页链接